Cardiomyopathy

(redirected from hypertrophic cardiomyopathy)
Also found in: Dictionary, Thesaurus, Medical, Acronyms, Wikipedia.
Related to hypertrophic cardiomyopathy: Hypertrophic obstructive cardiomyopathy

cardiomyopathy

[¦kärd·ē·ō‚mī′äp·ə·thē]
(medicine)

Cardiomyopathy

 

(myocardosis), a term often applied to a broad group of heart diseases; specifically, noninflammatory lesions of the heart muscle (myocardium) resulting from a disturbance in myocardial metabolism. Among the causes of cardiomyopathy are nutritional disorders (alimentary dystrophy and avitaminosis, for example); protein metabolism disorders in hepatic or renal insufficiency and podagra; disturbances of carbohydrate metabolism (diabetes mellitus) and electrolyte metabolism; and endocrine disorders such as those associated with thyrotoxicosis and with hypoxia in impairment of coronary circulation, anemia, and mountain sickness. Myocardosis may also be caused by overstraining the myocardium and by exogenous poisons, such as carbon monoxide and alcohol.

In many cases the patient has no specific symptoms in the early stages; however, there may be shortness of breath and disagreeable sensations in the heart. Cardiomyopathy is manifested by dull, distant heart sounds, electrocardiographic changes, systolic murmur, extrasystole, and, more rarely, other types of arrhythmia. Severe cardiomyopathy weakens the heart contractions and may cause cardiac insufficiency. The changes associated with cardiomyopathy are usually reversible and disappear with the elimination of the underlying disease.

The cure includes treatment of the underlying disease and administration of agents that improve metabolic processes in the myocardium.

REFERENCE

Kedrov, A. A. Bolezni myshtsy serdtsa. Leningrad, 1963.

N. R. PALEEV

References in periodicals archive ?
Long-term survival in patients with resting obstructive hypertrophic cardiomyopathy comparison of conservative versus invasive treatment.
These findings were consistent with hypertrophic cardiomyopathy (mid cavity type).
Is the apical hypertrophic cardiomyopathy seen in one population in Rio de Janeiro city similar to that found in the east?
The report reviews key players involved Hypertrophic Cardiomyopathy therapeutics and enlists all their major and minor projects
A novel mutation of the beta myosin heavy chain gene responsible for familial hypertrophic cardiomyopathy.
Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in the CARDIA study.
5 Therefore, we herein aimed to study the effects of low-dose amiodarone in combination with Betaloc on hypertrophic cardiomyopathy complicated with malignant ventricular arrhythmias.
There are no published studies regarding mutations on clinical cases of hypertrophic cardiomyopathy in Venezuela.
Hypertrophic cardiomyopathy increases the risk of sudden death during physical exercise.
Now Stanford University School of Medicine researchers have, for the first time, identified the molecular basis for a condition called hypertrophic cardiomyopathy that is the most common cause for this type of sudden cardiac death.

Full browser ?